Published in Cancer on September 01, 1970
The problem of caring for the dying in a general hospital; the palliative care unit as a possible solution. Can Med Assoc J (1976) 4.65
The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol (1970) 4.55
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med (1995) 3.39
Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med (1997) 3.31
Use of the Brompton mixture in treating the chronic pain of malignant disease. Can Med Assoc J (1976) 3.24
The Brompton mixture: effects on pain in cancer patients. Can Med Assoc J (1976) 2.36
The biology of teratomas. Adv Morphog (1967) 2.36
The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev Biol (1974) 2.31
The Brompton mixture versus morphine solution given orally: effects on pain. Can Med Assoc J (1979) 2.23
Epidemiology of cancer of the prostate. Cancer (1971) 2.19
Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins. Proc Natl Acad Sci U S A (1981) 2.09
Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst (1967) 2.07
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 2.02
A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst (1973) 1.85
Recent results of management of palpable clinically localized prostate cancer. Cancer (1993) 1.78
The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. Int J Radiat Oncol Biol Phys (1994) 1.73
Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. J Urol (1993) 1.72
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol (1995) 1.71
Living with the dying: use of the technique of participant observation. Can Med Assoc J (1976) 1.69
Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division. Nature (1977) 1.68
Intermittent endocrine therapy for advanced prostate cancer. Cancer (1986) 1.60
Death and dying: attitudes in a teaching hospital. Urology (1974) 1.59
Sarcomas of the kidney. J Urol (1984) 1.58
Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst (1974) 1.58
The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys (1991) 1.58
Experience with carcinoma of the scrotum. J Urol (1977) 1.57
Dealing with our losses. J Clin Oncol (1986) 1.56
The response of metastatic adenocarcinoma of the prostate to exogenous testosterone. J Urol (1981) 1.55
Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire. Cancer (1996) 1.52
Cryptorchidism and testicular cancer. J Urol (1980) 1.52
Solitary metastasis from renal cell carcinoma. J Urol (1975) 1.52
Spermatic cord sarcoma in adults. J Urol (1978) 1.48
125I implantation for carcinoma of prostate. Further follow-up of first 100 cases. Urology (1982) 1.47
Review of an 8-year experience with modifications of endoscopic suspension of the bladder neck for female stress urinary incontinence. J Urol (1990) 1.43
Determination of sex of teratomas derived from early mouse embryos. J Natl Cancer Inst (1970) 1.43
Management of clinically localized prostatic cancer. An unresolved problem. JAMA (1993) 1.40
Testicular cancer in cryptorchids. Cancer (1982) 1.39
Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res (1983) 1.38
Cystectomy + diversion for carcinoma of the bilharzial bladder. Prog Clin Biol Res (1988) 1.37
Palliative care--a passing fad? Understanding and responding to the signs of the times. J Palliat Care (1994) 1.28
Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer (1982) 1.27
Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol (1977) 1.24
The evolution of mature teratoma from malignant testicular tumors. Cancer (1977) 1.24
Toxicity of intravesical BCG and its management in patients with superficial bladder tumors. Cancer (1987) 1.23
International group issues proposal for standards for care of terminally ill. Can Med Assoc J (1979) 1.22
Proceedings: Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer (1974) 1.22
Natural history and staging of prostate cancer. Urol Clin North Am (1984) 1.21
Changes in quality of life following admission to palliative care units. Palliat Med (2001) 1.18
Penile cancer: relation of extent of nodal metastasis to survival. J Urol (1987) 1.16
Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer (1977) 1.16
Cis-dichlorodiammineplatinum(II) in advanced bladder cancer. Cancer Treat Rep (1976) 1.15
Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. J Histochem Cytochem (1984) 1.15
Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc Natl Acad Sci U S A (1985) 1.14
Proceedings: The natural history of prostatic cancer. Cancer (1973) 1.14
Regional lymph node metastasis from bladder cancer. J Urol (1981) 1.14
Complications of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer. J Urol (1979) 1.13
Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report. Cancer (1985) 1.13
Lymphocyte stimulation: selective destruction of cells during blastogenic response to transplantation antigens. Science (1971) 1.13
Malignant tumors of the spermatic cord. Cancer (1969) 1.13
Exercise duration and mood state: how much is enough to feel better? Health Psychol (2001) 1.12
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. J Clin Oncol (1988) 1.11
The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer (1987) 1.10
Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors. J Urol (1983) 1.09
Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet Cytogenet (1987) 1.09
Expectant management of clinically localized prostatic cancer. J Urol (1994) 1.09
Primary carcinoma of the ureter: a prognostic study. Cancer (1975) 1.08
Implantation of 125I in prostatic cancer. Surg Clin North Am (1974) 1.08
Living with cancer: "good" days and "bad" days--what produces them? Can the McGill quality of life questionnaire distinguish between them? Cancer (2000) 1.08
Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors. J Urol (1983) 1.06
Sequential bilateral germ cell tumors of the testis despite interval chemotherapy. J Urol (1979) 1.05
Behavioral patterns of prostate adenocarcinoma following an 125I implant and pelvic node dissection. Int J Radiat Oncol Biol Phys (1977) 1.04
Adriamycin in advanced urinary tract cancer: experience in 42 patients and review of the literature. Cancer (1977) 1.03
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. J Clin Oncol (1987) 1.03
Combined chemotherapy and surgery in treatment of advanced germ-cell tumors. Cancer (1981) 1.03
Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder. Cancer (1983) 1.02
Aphakia, a new mutation in the mouse. J Hered (1968) 1.02
VAB-6 combination chemotherapy in disseminated cancer of the testis. Ann Intern Med (1981) 1.01
Development in vitro of mouse embryos from the two-cell egg stage to the early somite stage. J Embryol Exp Morphol (1974) 1.01
Intratesticular germ cell tumors: observations on the effect of chemotherapy. J Urol (1981) 1.00
Primordial germ cell proliferation in fetal testes in mouse strains with high and low incidences of congenital testicular teratomas. J Natl Cancer Inst (1982) 1.00
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J Urol (1989) 1.00
Human and mouse embryonal carcinoma cells in culture share an embryonic antigen (F9). Nature (1977) 0.99
Primary mediastinal germ cell tumors. Cancer (1974) 0.99
Surgical treatment of adult germinal testis tumors. Semin Oncol (1979) 0.98
Development of resistance to teratocarcinogenesis by primordial germ cells in mice. J Natl Cancer Inst (1966) 0.97
Seminal fluid and spermatozoon zinc levels and their relationship to human spermatozoon motility. Fertil Steril (1971) 0.97
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J Clin Oncol (1984) 0.97
Adriamycin and cyclophosphamide in advanced bladder cancer. Cancer Treat Rep (1977) 0.97
Ethical issues in palliative care research revisited. Palliat Med (1995) 0.96
The management of intractable pain in patients with advanced malignant disease. J Urol (1978) 0.96
Viable chimaeras produced from normal and parthenogenetic mouse embryos. Nature (1977) 0.96
VAB-4 combination chemotherapy in the treatment of metastatic testis tumors. Cancer (1981) 0.96
An overview of intravesical therapy for superficial bladder tumors. J Urol (1987) 0.95
Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management. J Urol (1987) 0.95
Renal pelvic tumors. JAMA (1971) 0.95
Development of teratomas from the ectoderm of mouse egg cylinders. J Natl Cancer Inst (1976) 0.94
Spontaneous and experimentally induced testicular teratomas in mice. Cell Differ (1984) 0.94
Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol (1977) 0.94
The role of neoadjuvant hormonal manipulation in localized prostatic cancer. Cancer (1993) 0.93